Inhibition of HIV Env binding to cellular receptors by monoclonal antibody 2GI2 as probed by Fc-tagged gp120

被引:28
作者
Binley, James M.
Ngo-Abdalla, Stacie
Moore, Penny
Bobardt, Michael
Chatterji, Udayan
Gallay, Philippe
Burton, Dennis R.
Wilson, Ian A.
Elder, John H.
de Parseval, Aymeric
机构
[1] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA
[2] Torrey Pines Inst Mol Studies, San Diego, CA 92121 USA
[3] Natl Inst Communicable Dis, ZA-2131 Johannesburg, South Africa
[4] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[5] Scripps Res Inst, Dept Immunol & Mol Biol, La Jolla, CA 92037 USA
[6] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA
[7] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA
关键词
D O I
10.1186/1742-4690-3-39
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
During natural HIV infection, an array of host receptors are thought to influence virus attachment and the kinetics of infection. In this study, to probe the interactions of HIV envelope ( Env) with various receptors, we assessed the inhibitory properties of various anti-Env monoclonal antibodies (mAbs) in binding assays. To assist in detecting Env in attachment assays, we generated Fc fusions of full-length wild-type gp120 and several variable loop-deleted gp120s. Through investigation of the inhibition of Env binding to cell lines expressing CD4, CCR5, DC-SIGN, syndecans or combinations thereof, we found that the broadly neutralizing mAb, 2G12, directed to a unique carbohydrate epitope of gp120, inhibited Env-CCR5 binding, partially inhibited Env-DC-SIGN binding, but had no effect on Env-syndecan association. Furthermore, 2G12 inhibited Env attachment to primary monocyte-derived dendritic cells, that expressed CD4 and CCR5 primary HIV receptors, as well as DC-SIGN, and suggested that the dual activities of 2G12 could be valuable in vivo for inhibiting initial virus dissemination and propagation.
引用
收藏
页数:15
相关论文
共 88 条
  • [1] Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination
    Barouch, DH
    Santra, S
    Schmitz, JE
    Kuroda, MJ
    Fu, TM
    Wagner, W
    Bilska, M
    Craiu, A
    Zheng, XX
    Krivulka, GR
    Beaudry, K
    Lifton, MA
    Nickerson, CE
    Trigona, WL
    Punt, K
    Freed, DC
    Guan, LM
    Dubey, S
    Casimiro, D
    Simon, A
    Davies, ME
    Chastain, M
    Strom, TB
    Gelman, RS
    Montefiori, DC
    Lewis, MG
    Emini, EA
    Shiver, JW
    Letvin, NL
    [J]. SCIENCE, 2000, 290 (5491) : 486 - 492
  • [2] Potent broad cross-neutralizing sera inhibit attachment of primary HIV-1 isolates (groups M and O) to peripheral blood mononuclear cells
    Beirnaert, E
    De Zutter, S
    Janssens, W
    van der Groen, G
    [J]. VIROLOGY, 2001, 281 (02) : 305 - 314
  • [3] Vesicular stomatitis virus expressing a chimeric Sindbis glycoprotein containing an Fc antibody binding domain targets to Her2/neu overexpressing breast cancer cells
    Bergman, I
    Whitaker-Dowling, P
    Gao, YH
    Griffin, JA
    Watkins, SC
    [J]. VIROLOGY, 2003, 316 (02) : 337 - 347
  • [4] Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies
    Binley, JA
    Wrin, T
    Korber, B
    Zwick, MB
    Wang, M
    Chappey, C
    Stiegler, G
    Kunert, R
    Zolla-Pazner, S
    Katinger, H
    Petropoulos, CJ
    Burton, DR
    [J]. JOURNAL OF VIROLOGY, 2004, 78 (23) : 13232 - 13252
  • [5] Analysis of the interaction of antibodies with a conserved, enzymatically deglycosylated core of the HIV type 1 envelope glycoprotein 120
    Binley, JM
    Wyatt, R
    Desjardins, E
    Kwong, PD
    Hendrickson, W
    Moore, JP
    Sodroski, J
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1998, 14 (03) : 191 - 198
  • [6] Redox-triggered infection by disulfide-shackled human immunodeficiency virus type 1 pseudovirions
    Binley, JM
    Cayanan, CS
    Wiley, C
    Schülke, N
    Olson, WC
    Burton, DR
    [J]. JOURNAL OF VIROLOGY, 2003, 77 (10) : 5678 - 5684
  • [7] Preferential attachment of HIV particles to activated and CD45RO+CD4+ T cells
    Blanco, J
    Barretina, J
    Gutiérrez, A
    Armand-Ugón, M
    Cabrera, C
    Clotet, B
    Esté, JA
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2002, 18 (01) : 27 - 38
  • [8] Syndecan captures, protects, and transmits HIV to T lymphocytes
    Bobardt, MD
    Saphire, ACS
    Hung, HC
    Yu, XC
    Van der Schueren, B
    Zhang, Z
    David, G
    Gallay, PA
    [J]. IMMUNITY, 2003, 18 (01) : 27 - 39
  • [9] Attachment of human immunodeficiency virus-1 (HIV-1) particles bearing host-encoded B7-2 proteins leads to nuclear factor-κB- and nuclear factor of activated T cells-dependent activation of HIV-1 long terminal repeat transcription
    Bounou, S
    Dumais, N
    Tremblay, MJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (09) : 6359 - 6369
  • [10] Polyclonal immunoglobulin G from patients neutralizes human immunodeficiency virus type 1 primary isolates by binding free virions, but without interfering with an initial CD4-independent attachment of the virus to primary blood mononuclear cells
    Burrer, R
    Haessig-Einius, S
    Aubertin, AM
    Moog, C
    [J]. JOURNAL OF VIROLOGY, 2003, 77 (21) : 11385 - 11397